Catalyst Pharmaceuticals (CPRX) Other Non Operating Income (2012 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Other Non Operating Income of $11.0 million for Q1 2026, up 172.65% on a QoQ basis from -$15.1 million in Q4 2025, and up 38.87% year-over-year from $7.9 million in Q1 2025.
Catalyst Pharmaceuticals (CPRX) Other Non Operating Income (2012 - 2026) Analysis & Trends
Catalyst Pharmaceuticals' Other Non Operating Income history runs 15 years deep, the most recent figure standing at $11.0 million for Q1 2026.
- Quarterly Other Non Operating Income rose 38.87% year-over-year to $11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (down 86.62% YoY) and the FY2025 annual result came in at $546000.0, down 97.42% from the prior year.
- Other Non Operating Income was $11.0 million for Q1 2026 at Catalyst Pharmaceuticals, up from -$15.1 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $11.3 million in Q4 2024 and bottomed at -$15.1 million in Q4 2025.
- A 5-year average of $2.4 million and a median of $1.8 million in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income tumbled 815.49% — and 2023, when it jumped 1732.26%.
- Catalyst Pharmaceuticals' Other Non Operating Income stood at -$508000.0 in 2022, then soared by 1087.2% to $5.0 million in 2023, then soared by 126.08% to $11.3 million in 2024, then tumbled by 233.5% to -$15.1 million in 2025, then jumped by 172.65% to $11.0 million in 2026.
- Business Quant data shows CPRX's Other Non Operating Income at $11.0 million in Q1 2026, -$15.1 million in Q4 2025, and $4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.00 Mn |
| Dec 31, 2025 | -15.14 Mn |
| Sep 30, 2025 | 4.77 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 7.92 Mn |
| Dec 31, 2024 | 11.34 Mn |
| Sep 30, 2024 | 6.30 Mn |
| Jun 30, 2024 | 1.54 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Dec 31, 2023 | 5.02 Mn |
| Sep 30, 2023 | -833,000.00 |
| Jun 30, 2023 | 1.81 Mn |
| Mar 31, 2023 | 1.70 Mn |
| Dec 31, 2022 | -508,000.00 |
| Sep 30, 2022 | 905,000.00 |
| Jun 30, 2022 | -324,000.00 |
| Mar 31, 2022 | 93,000.00 |
| Dec 31, 2021 | 71,000.00 |
| Sep 30, 2021 | 68,000.00 |
| Jun 30, 2021 | 62,000.00 |